ABSTRACT Dementia is a syndrome that affects millions of people in the world, and Alzheimer's disease (AD) is the most common cause. The diagnosis of AD begins with cognitive symptoms such as mild cognitive impairment (MCI) but requires the demonstration and quantification of the underlying neuropathological processes...
Marcello Berto, P. A. Manco Urbina, A. Paradisi et al.· Advanced Healthcare Material...· 0 citations
The real-world diagnostic journey, barriers, and management pathways of MCI and mild AD dementia patients in Italy is characterized to characterize the real-world diagnostic journey, barriers, and management pathways of biomarker-based diagnostics in Italy.
S. Ippati, Federico Torelli, Giovanna Zamboni et al.· Journal of Alzheimer's Disea...· 0 citations
Cognitive and CSF phenotype of LO-TLE with normal CSF AD biomarkers is characterized by distinct cognitive and biological features compared with MCI-AD, suggesting a disease process independent of AD.
Alessia Casarini, Alice Ballerini, Riccardo Maramotti et al.· Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.